Gregorius M. Luyten
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Choroidal melanoma patient views on the importance of treatment characteristics and outcomes, and physicians' information provision in the Netherlands.
Journal: Acta ophthalmologica
Published: December 05, 2024
MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma.
Journal: Neuroradiology
Published: February 06, 2023
Prevalence of Myopic Macular Features in Dutch Individuals of European Ancestry With High Myopia.
Journal: JAMA ophthalmology
Published: December 16, 2021
Two Late Recurrences of Conjunctival Melanoma.
Journal: Ocular oncology and pathology
Published: September 03, 2018
Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma.
Journal: Molecular cancer research : MCR
Published: February 02, 2018
Lack of tumour pigmentation in conjunctival melanoma is associated with light iris colour and worse prognosis.
Journal: The British journal of ophthalmology
Published: January 30, 2018
ECCO essential requirements for quality cancer care: Melanoma.
Journal: Critical reviews in oncology/hematology
Published: December 31, 2017
Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.
Journal: Acta ophthalmologica
Published: September 21, 2017
Pimasertib-associated ophthalmological adverse events.
Journal: Acta ophthalmologica
Published: August 28, 2017
Treatment of conjunctival melanoma in a Dutch referral centre.
Journal: The British journal of ophthalmology
Published: July 21, 2017
Ruthenium-106 brachytherapy for iris and iridociliary melanomas.
Journal: The British journal of ophthalmology
Published: May 22, 2017
Conjunctival Metastasis of a Cutaneous Melanoma.
Journal: Ocular oncology and pathology
Published: May 03, 2017
Last Updated: 09/26/2026